To help you get into the multiplexing workflow efficiently, there are a few key points to consider:
Figure 1. SolisFAST® Probe qPCR Mix (ROX) was used in a 4-plex probe-based qPCR with fourteen fold serial dilutions of human gDNA (40 ng –40 pg per reaction, three replicates at each concentration). qPCR was performed on a QuantStudio™ 6 Flex qPCR cycler (Applied BioSystems™) using ROX dye for normalization.
Using regular qPCR mixes in highly multiplexed assays carries a number of risks, such as late Ct values, low efficiency, low sensitivity, and low fluorescence. As regular qPCR mixes do not have a sufficient amount of components for amplifying more than 2 targets simultaneously, you are running the risk of getting false-negative results. Using specifically designed multiplex mixes will greatly increase your success.
For fast cycling speed and up to 5-plex reactions:
For standard cycling speed and up to 4-plex reactions:
By using the right product designed for multiplexing, you can rest assured you will enjoy similar sensitivity to singleplexing with a greatly reduced workload.
Figure 2. HOT FIREPol® Multiplex qPCR Mix (Purple) was used to perform 4-plex or single-plex probe-based qPCR with five tenfold serial dilutions of human cDNA (cDNA concentration ranges from 200 ng to 20 pg per reaction). Reactions were performed with Applied BioSystems™ QuantStudio™ 6 cycler using Purple dye for normalization.
Meet our next-generation FIREScript® reverse transcriptases: fast, thermostable enzymes with distinct RNase H profiles for flexible cDNA synthesis and RT-qPCR workflows.
Summer has a way of changing the rhythm of a laboratory. Temperatures rise, team members take well-earned holidays, and deliveries do not always arrive exactly when expected. A shipment may take longer in transit than planned. A package might reach the laboratory on a particularly hot afternoon. With Solis BioDyne’s products, summer heat does not have to bring research to a standstill.
From 2010, Solis BioDyne had stepped into a whole new area of enzyme development. What began as an ambitious R&D project led to FIREScript®, SOLIScript®, RiboGrip® RNase Inhibitor, and the SolisFAST® product line. Find out more about the development process in this blog post.
In high-throughput environments such as diagnostic kit development, pharmaceutical research, and OEM manufacturing, reducing PCR and qPCR costs is rarely as simple as choosing the lowest-priced reagent. Cost per reaction is often the first metric considered, but it does not fully reflect the true financial impact of a workflow.